2020
DOI: 10.1038/s41375-020-0932-8
|View full text |Cite
|
Sign up to set email alerts
|

Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 38 publications
0
15
0
Order By: Relevance
“…11 Both mutations are early events and are associated with clonal dominance in single-cell genotyping studies, 47 a feature that is associated with a poorer prognosis in AML. 48 Mouse models suggest an epigenetic cooperation between the 2 alterations, leading to activation of a stem cell-like gene signature. 49 Following previous reports in refractory/relapsing IDH-mutated AML, 50,51 it will be interesting to further study the genetic landscape and molecular predictors in patients with relapsed IDH-mutated AML, to compare trials conducted in this population.…”
Section: Discussionmentioning
confidence: 99%
“…11 Both mutations are early events and are associated with clonal dominance in single-cell genotyping studies, 47 a feature that is associated with a poorer prognosis in AML. 48 Mouse models suggest an epigenetic cooperation between the 2 alterations, leading to activation of a stem cell-like gene signature. 49 Following previous reports in refractory/relapsing IDH-mutated AML, 50,51 it will be interesting to further study the genetic landscape and molecular predictors in patients with relapsed IDH-mutated AML, to compare trials conducted in this population.…”
Section: Discussionmentioning
confidence: 99%
“…Exome sequencing or targeted sequencing of panels including at least 50–100 genes recurrently mutated in AML can capture partial information on clonal structure. These approaches often compensate their limited coverage compared with WGS with greater depth, allowing more precise assessment of VAFs and more robust clustering of the variants captured [ 5 , 17 , 18 , 19 , 20 ]. Single-colony [ 5 , 6 , 21 ], plate-based single cell [ 22 , 23 ], and more recently, high-throughput, droplet-based genotyping protocols [ 24 , 25 ] have contributed to describe the exact clonal composition of AML ( Figure 1 ).…”
Section: Clonal Identity In Amlmentioning
confidence: 99%
“…Different indices exist to quantify alpha diversity [ 62 ]. The most frequently used are the number of clones [ 12 , 25 ], which is sometimes approximated by counting the number of mutations in the most recurrent AML oncogenes [ 17 , 63 ], Shannon’s index [ 17 , 24 , 25 ], and Simpson’s index [ 17 ].…”
Section: Origin Of Intraleukemic Heterogeneity and Clonal Evolutionmentioning
confidence: 99%
See 1 more Smart Citation
“…In chronic lymphocytic leukemia, an increased number of sub-clonal driver mutations was associated with an inferior failure-free survival while an increase of clonal drivers was not. 29 In acute myeloid leukemia, clonal dominance has been associated with a worse prognosis, 30 while branched evolution of signaling mutations conveyed an inferior event-free survival compared to linear evolution. 31 These various associations between clonal architecture and clinical outcomes highlight the importance of understanding the underlying processes that drive clonal architecture.…”
Section: Introductionmentioning
confidence: 99%